Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1209-1215

  Ashcroft, Gillian S ^a,b   Dodsworth, Joanne ^a   Van Boxtel, Egon ^b   Tarnuzzer, Roy W ^c   Horan, Michael A ^b   Schultz, Gregory S ^c   Ferguson, Mark W J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TRANSFORMING GROWTH FACTOR BETA1;

AGING; ARTICLE; ESTROGEN BLOOD LEVEL; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; OVARIECTOMY; PRIORITY JOURNAL; SCAR FORMATION; SKIN FIBROBLAST; SKIN INCISION; WOUND HEALING;

RODENTIA;

EID: 0030669690     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197-1209     Document Type: Article

References (22)

1. Ashcroft, G.S., Horan, M.A. & Ferguson, M.W.J. A review: The effects of ageing on cutaneous wound healing in mammals. J. Anat. 187, 1-26 (1995).
2. Whitby, D.J. & Ferguson, M.W.J. Immunohistochemical localization of growth factors in fetal wound healing. Dev. Biol. 147, 207-215 (1991).
3. Frazier-Jensen, M.R. et al. Estrogen suppression of connective tissue deposition in a murine model of peritoneal adhesion formation. J. Immunol. 156, 3036 (1996).
4. Bolognia, J.L. Aging skin. Am. J. Med. 98, 99s-103s (1995).
5. Schmidt, J.B. et al. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds; A pilot study. Maturitas 20, 25-30 (1994).
6. Pierard, G.E., Letawe, C., Dowlati, A. & Pierard-Franchimont, C. Effect of hormone replacement therapy for menopause on the mechanical properties of the skin. J. Am. Geriatr. Soc. 43, 662-665 (1995).
7. Oursler, M.J. et al. Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone. Endocrinology 129, 3313-3320 (1991).
8. Piccinni, M.P. et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clone. J. Immunol. 155, 128-133 (1995).
9. Pierce, G.F. et al. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J. Cell Biol. 109, 429-440 (1989).
10. Sporn, M.B. & Roberts, A.B. Transforming growth factor-β: Recent progress and new challenges. J. Cell Biol. 119, 1017-1021 (1992).
11. Beck, L.S. et al. One systemic administration of transforming growth factor-β1 reverses age-or glucocorticoid-impaired wound healing. J. Clin. Invest. 92, 2841-2849 (1993).
12. Shah, M., Foreman, D.M. & Ferguson, M.W.J. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet 339, 213-214 (1992).
13. Colletta, A.A. et al. The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta. J. Clin. Invest. 87, 277-283 (1991).
14. Yang, N.N. et al. Estrogen and raloxifene stimulate transforming growth factor-β3 gene expression in rat bone: A potential mechanism for estrogen-or raloxifene-mediated bone maintenance. Endocrinology 137, 2075-20 (1996)
15. Malet, C. et al. Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: Immunocytochemical studies. J. Clin. Endocrin. Metab. 73, 8-13 (1991).
16. Reed, M.J. et al. TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J. Cell. Physiol. 158, 169-179 (1994).
17. Ligthart, G.J. et al. Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mech. Ageing Dev. 28, 47-55 (1984).
18. Ashcroft, G.S., Horan, M.A. & Ferguson, M.W.J. Ageing is associated with reduced deposition of specific extracellular matrix components, an up-regulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model. J. Invest. Dermatol. 108, 430-437 (1997).
19. Overall, C.M. Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: Comparison with transforming growth factor-β1. J. Cell. Physiol. 164, 17-25 (1995).
20. Danielpour, D., Dart, L.L., Flanders, K.C., Roberts, A.B. & Sporn, M.B. Immunodetection and quantitation of two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol. 138, 79-86 (1989).
21. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
22. Tarnuzzer, R.W. et al. Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR. Biotechniques 20, 670-674 (1996).